BELLICUM PHARMACEUTICALS INC (BLCM)
US0794814048 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.48M | -24.97M | -9.71M | -7.72M | -112.48M | |||
| Depreciation Amortization | 9.00K | 11.00K | 105.00K | 1.47M | 7.18M | |||
| Change In Working Capital | 1.24M | -1.47M | -2.35M | -8.16M | -6.90M | |||
| Interest Paid | N/A | N/A | 0.00 | 2.34M | 3.20M | |||
| Other non cash items | -1.61M | 645.00K | -11.15M | -42.24M | 34.64M | |||
| OPERATING CASH FLOW | -25.84M | -25.78M | -23.11M | -56.65M | -77.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.00K | -21.00K | -7.00K | -630.00K | -520.00K | |||
| Other Investing Activity | N/A | 0.00 | 900.00K | 14.71M | 49.38M | |||
| INVESTING CASH FLOW | -19.00K | -21.00K | 893.00K | 14.08M | 48.86M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -35.00K | -37.23M | -50.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 32.91M | 22.99M | 62.98M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 11.15M | |||
| FINANCING CASH FLOW | N/A | 0.00 | 32.87M | -14.24M | 74.09M | |||
| Exchange Rate Effect | -13.00K | -16.00K | 1.00K | -10.00K | -230.00K | |||
| CHANGE IN CASH | -25.87M | -25.82M | 10.66M | -56.82M | 45.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.84M | -25.78M | -23.11M | -56.65M | -77.57M | |||
| Capital Expenditure | -19.00K | -21.00K | -7.00K | -630.00K | -520.00K | |||
| FREE CASH FLOW | -25.86M | -25.80M | -23.11M | -57.28M | -78.09M | |||
All data in USD